Happy to load more shares at this price with some great news on the way by the end of this quarter. The Phase 3 cell test facility was installed and commissioned during last quarter. With this facility, LIS can complete UN38.3 battery safety and performance testing, deliver test data for cell performance data sheets, and conduct bespoke cell performance testing to match partner specific device and mission parameters.
The facility also offers a potential opportunity to generate revenue through advanced cell testing services for other industry partners. Phase 3 gives LIS the opportunity to achieve commercial scale, providing high-quality cells in volume, moving beyond scientific labs and into scaled manufacturing.
LIS Price at posting:
15.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)